01 Jul Date July 1, 2021 Categories Blog First Comfort Laboratories Announces Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in Singapore This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.
19 May Date May 19, 2021 Categories Blog First Comfort Laboratories Appoints Debra Hussain as Chief Commercial Officer THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION – THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
13 Aug Date August 13, 2020 Categories Blog Interim Results for the Six Months ended 30 June 2020 First Comfort Laboratories Singapore (“First Comfort Laboratories” or the “Company” and, together with its subsidiaries, the “Group”) (EURONEXT: ACPH), a commercial stage